Over-the-Counter and Compounded Vitamin D: Is Potency What We Expect?
Author(s) -
Erin S. LeBlanc,
Nancy Perrin,
Jeffery D. Johnson,
Annie M. Ballatore,
Teresa A. Hillier
Publication year - 2013
Publication title -
jama internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.14
H-Index - 342
eISSN - 2168-6114
pISSN - 2168-6106
DOI - 10.1001/jamainternmed.2013.3812
Subject(s) - medicine , potency , over the counter , traditional medicine , pharmacology , biochemistry , medical prescription , chemistry , in vitro
B ecause vitamin D insufficiency can be harmful to health, supplementation is often prescribed. However, the Food and Drug Administration (FDA) does not regulate vitamin D supplements, so potency may not be well evaluated. In a recent trial examining vitamin D in menopausal women, we found that compounded vitamin D3 (cholecalciferol) supplements varied significantly in potency. Only one-third of our compounded study pills met US Pharmacopeial (USP) Convention standards, which require that compounded pills contain 90% to 110% of the active ingredient. This variability in compounded cholecalciferol pills led us to additionally investigate over-the-counter (OTC) cholecalciferol pills, in which we also found variability.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom